MDPK67b in Patients With Prostate Cancer
Phase 1
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Drug: MDPK67b
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Med Discovery SA
- Target Recruit Count
- 15
- Registration Number
- NCT05580107
- Locations
- 🇨ðŸ‡
Klinik für Urologie, UniversitätSpital Zürich (USZ), Zürich, Switzerland
PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers
Phase 1
Completed
- Conditions
- Prostatic Neoplasms
- Interventions
- Drug: MDPK67bDrug: Placebo
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2021-04-09
- Lead Sponsor
- Med Discovery SA
- Target Recruit Count
- 8
- Registration Number
- NCT04839120
- Locations
- 🇨ðŸ‡
Centre Hospitalier Universitaire Vaudois (CHUV) - Division of Clinical Pharmacology, Lausanne, Switzerland
© Copyright 2025. All Rights Reserved by MedPath